May 4, 2016: Integrium to Attend Marcum MicroCap Conference in June 2016

By Emily MacHale
May 4, 2016
Tustin, CA - Integrium Clinical Research announced they will be attending the 2016 Marcum MicroCap Conference on June 1st through 2nd at the Grand Hyatt New York. Integrium executives look forward to meeting with prospective companies in the life science and healthcare sectors, as well as engaging in featured presentations of CEOs and CFOs.
Year after year, the Marcum MicroCap Conference has consistently provided publicly traded companies with less than $500 million in market capitalization the chance to network with the investment community. The conference consists of a full itinerary of expert panels on important topics related to the investment field. The event draws fund managers and high net worth investors who concentrate on small cap equities.
As before, Marcum is pleased to partner with KCSA Strategic Communications to present the 2016 Marcum MicroCap Conference.
About Integrium
Through a trusted partnership with PoC Capital, Integrium is able to assist Micro Cap, Small Cap, and Privately held Biotechs looking to raise additional financing, by providing new clinical data to create the next bump in valuation. Integrium’s areas of therapeutic focus include Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Gene Therapy, and Orphan Diseases.
To learn more about Integrium Clinical Research, please contact:
Mike Loftus
Executive Director, Business Development Phone: (908) 295-4578